Basit öğe kaydını göster

dc.contributor.authorErhamamci, Seval
dc.contributor.authorAslan, Nesrin
dc.date.accessioned2021-03-31T12:31:10Z
dc.date.available2021-03-31T12:31:10Z
dc.date.issued2020
dc.identifier.issn0363-9762en_US
dc.identifier.urihttp://hdl.handle.net/11727/5651
dc.description.abstractGa-68-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-18-FDG PET/CT imaging for initial staging. The patient underwent F-18-FDG PET/CT as part of staging procedure; he also underwent Ga-68-PSMA PET/CT. PET/CT images revealed only slight F-18-FDG uptake in the liver lesion, but intense Ga-68-PSMA uptake, without any metastatic lesion seen elsewhere in the body.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1097/RLU.0000000000002922en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectF-18-FDGen_US
dc.subjectGa-68-PSMAen_US
dc.subjectPETen_US
dc.subjectCTen_US
dc.subjecthepatocellular carcinomaen_US
dc.titlePrimary Hepatocellular Carcinoma With Intense Ga-68-PSMA Uptake But Slight F-18-FDG Uptake on PET/CT Imagingen_US
dc.typeeditorialen_US
dc.relation.journalCLINICAL NUCLEAR MEDICINEen_US
dc.identifier.volume45en_US
dc.identifier.issue3en_US
dc.identifier.startpageE176en_US
dc.identifier.endpageE177en_US
dc.identifier.wos000514881600017en_US
dc.contributor.pubmedID31977478en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster